Complete Remission of Squamous Cell Carcinoma After Treatment With Panitumumab in a Patient With Cetuximab-Induced Anaphylaxis

JAMA Dermatol. 2016 Mar;152(3):343-5. doi: 10.1001/jamadermatol.2015.4134.

Authors

Aurélie Marti¹, Antoine Fauconneau¹, Nora Ouhabrache², Marie Beylot-Barry¹, Anne Pham-Ledard¹

Affiliations

¹ Dermatology Department, CHU de Bordeaux, University of Bordeaux, Bordeaux, France.
² Radiotherapy Department, CHU de Bordeaux, Hôpital Haut Lévêque, Bordeaux France.

PMID: 26606112
DOI: 10.1001/jamadermatol.2015.4134

No abstract available

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Anaphylaxis / chemically induced*
Antibodies, Monoclonal / therapeutic use*
Carcinoma, Squamous Cell / drug therapy*
Carcinoma, Squamous Cell / pathology
Cetuximab / administration & dosage*
Cetuximab / therapeutic use
Drug Substitution
Humans
Male
Neoplasm Invasiveness
Neoplasm Staging
Panitumumab
Remission Induction
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology

Substances

Antibodies, Monoclonal
Panitumumab
Cetuximab